A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT06516068 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2025-07-16
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Conditions
Interventions
- DRUG
-
HRS-1893
HRS-1893
Sponsors & Collaborators
-
Shandong Suncadia Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-11
- Primary Completion
- 2024-11-18
- Completion
- 2025-08-31
Countries
- China
Study Locations
More Related Trials
-
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
NCT06820099 ·Status: RECRUITING ·Phase: PHASE2
-
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
NCT06391710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
NCT04164732 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of HRS-1893 in Healthy Volunteers
NCT07033455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
NCT00354328 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
NCT00091520 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01541202 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients
NCT01439893 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
NCT04826185 ·Status: COMPLETED ·Phase: PHASE2
-
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients
NCT03816306 ·Status: COMPLETED
-
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
NCT06116968 ·Status: COMPLETED ·Phase: PHASE3
-
Pirfenidone to Treat Hypertrophic Cardiomyopathy
NCT00011076 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
NCT02431221 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
NCT06017609 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01131637 ·Status: TERMINATED ·Phase: PHASE3
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
NCT02862600 ·Status: TERMINATED ·Phase: PHASE2
-
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
NCT04982081 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
NCT07318103 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
NCT01922089 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants
NCT03026088 ·Status: TERMINATED ·Phase: PHASE4
-
Use of SGLT2i in noHCM With HFpEF
NCT06401343 ·Status: RECRUITING ·Phase: PHASE4